Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease [Phase 2]
A Phase 2 trial evaluating topiramate as an adjunct to amantadine for dyskinesia in Parkinson's disease was terminated; results posted in 20…
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian Syndrome [Phase 2]
Phase 2 clinical trial evaluating brain imaging with nuclear technology in individuals with Parkinson's disease and Parkinsonian syndrome co…
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID [Phase 3]
Phase 3 trial evaluating amantadine hydrogen chloride ER tablets in Parkinson's disease patients with Levodopa-induced dyskinesia was termin…
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID. [Phase 3]
Phase 3 trial of extended-release amantadine HCl for Parkinson's disease with levodopa-induced dyskinesias was terminated; results posted in…
-
FDA approval · 2019-04-02FDA Approved: SELEGILINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original application for Selegiline hydrochloride tablets from Rising Pharma Holdings, Inc., granting generic approval. The …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-03-29FDA Approved: RASAGILINE — Original Application (Micro Labs Limited)
The FDA approved Micro Labs Limited's original application for rasagiline, establishing a generic option for use in Parkinson's disease. Thi…
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Effect of Short-term Motilitone Therapy on Health-related Quality of Life in PD Patients With Gastrointestinal Symptoms [Phase 4]
Phase 4 trial update evaluating short-term Motilitone therapy effects on quality of life in Parkinson disease patients with gastrointestinal…
-
CLINICAL_TRIALS trial_result · 2019-03-25Clinical Trial Update: Prism Adaptation Treatment of Parkinson's Disease [NA]
A completed clinical trial investigating prism adaptation treatment for Parkinson's disease, with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-22Clinical Trial Update: Impact of Walking Practice on Persons With PD [NA]
Clinical trial update on walking practice for people with Parkinson's disease; terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-03-21Clinical Trial Update: Comparing the Therapeutic Efficacy and Safety of DA-9701 With Domperidone in Patients With Parkinson's Disease [Phase 4]
Phase 4 trial comparing DA-9701 with domperidone in Parkinson's disease to evaluate therapeutic efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2019-03-14Clinical Trial Update: Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Parkinson's Disease [Phase 2]
Phase 2 clinical trial update examining nilotinib's safety, tolerability, pharmacokinetics, and biomarkers in Parkinson's disease and Parkin…
-
CLINICAL_TRIALS trial_result · 2019-03-08Clinical Trial Update: Randomized Trial to Test the "Coordinated Care for Health Promotion and Activities in Parkinson's Disease" Intervention in the VA [NA]
Completed randomized trial evaluating a coordinated care intervention for Parkinson's disease; results posted in 2019.
-
CLINICAL_TRIALS research · 2019-03-05Clinical Trial Update: Exercise and Cognitive Training in Parkinson's Disease [NA]
A completed clinical trial evaluating the effects of exercise and cognitive training in Parkinson's disease with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants [Phase 2, Phase 3]
Phase 2/3 study updating results for TVP-1012 at 0.5 mg and 1 mg in Parkinson's Disease patients treated with levodopa; trial completed with…
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants [Phase 3]
Phase 3 long-term extension study in early Parkinson's disease completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: A Study of Tolerability and Efficacy of Cannabidiol on Tremor in Parkinson's Disease [Phase 2]
Phase 2 study evaluating tolerability and efficacy of cannabidiol on tremor in Parkinson's disease. The study is completed and results were …
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Telephone-Based Counseling for Depression in Parkinson's Disease [NA]
A completed clinical trial evaluating telephone-based counseling for depression in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2019-02-19Clinical Trial Update: Study to Evaluate the Impact of Using Wearable Devices in Addition to Standard Clinical Practice on Parkinson´s Subject Symptoms Management [Phase 4]
Phase 4 clinical trial evaluating the impact of using wearable devices in addition to standard clinical practice on Parkinson's disease symp…
-
CLINICAL_TRIALS research · 2019-02-18Clinical Trial Update: The Influence of Manual and Verbal Guidance for Therapeutic Results in People With Parkinson's Disease [NA]
A clinical trial update examining how manual and verbal guidance affects therapeutic outcomes in people with Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: The Role of Cerebellar Hyperactivity in Parkinson's Disease
The study evaluating cerebellar hyperactivity in Parkinson's disease has completed, with results posted on 2019-02-15.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Cough According to Stimulus Type in PD [Phase 1]
A Phase 1 study in Parkinson's disease evaluating cough responses to different stimulus types has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability, and Fall Risk Reduction in Parkinson Disease [Phase 2]
Phase 2 clinical trial evaluating L-Dihydoxyphenylserine for improving locomotion, postural stability, and reducing fall risk in Parkinson's…
-
CLINICAL_TRIALS research · 2019-02-15Clinical Trial Update: Turkish Version of Mini-BESTest, Validity and Reliability for Adult Participants With Sensoriomotor Impairments
This clinical trial update reports on the Turkish version of the Mini-BESTest and assesses its validity and reliability in adults with senso…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Exploring the Relationship Between Alpha-synucleinopathy Related Non-motor Symptom and Post-op. Delirium in Elderly Patients With Spine Surgery
A completed clinical trial (NCT02550626) investigated the relationship between alpha-synucleinopathy-related non-motor symptoms and postoper…
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Bone Mineral Density Changes Among Clinical Subtypes of Parkinson's Disease
This clinical trial update examines how bone mineral density changes vary among clinical subtypes of Parkinson's disease and their implicati…